
National Research Corporation NRC
€ 15.31
-4.16%
Geschäftsbericht 2025
hinzugefügt 05.03.2026
Land |
|
IPO-Jahr |
- |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBAL |
Anteile |
22.4 M |
Marktkapitalisierung |
$ 402 M |
EBITDA (LTM) |
$ 32.9 M |
P/E (LTM) |
28.39 |
P/S (LTM) |
3.04 |
EPS (LTM) |
0.66 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market | ||
|
Burning Rock Biotech Limited
BNR
|
$ 17.01 | -0.12 % | $ 179 M | Nasdaq Global Market | ||
|
Agilent Technologies
A
|
$ 118.41 | 0.73 % | $ 36 B | NYSE,SPB | ||
|
Medpace Holdings
MEDP
|
$ 427.96 | -0.55 % | $ 12.3 B | Nasdaq Global Select Market,SPB | ||
|
Myriad Genetics
MYGN
|
$ 4.01 | -20.38 % | $ 371 M | Nasdaq Global Select Market,SPB | ||
|
NeoGenomics
NEO
|
$ 8.9 | 0.51 % | $ 1.14 B | Nasdaq Global Select Market,SPB | ||
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market | ||
|
Natera
NTRA
|
$ 216.86 | 4.88 % | $ 21.3 B | Nasdaq Global Select Market,SPB | ||
|
Koninklijke Philips N.V.
PHG
|
$ 27.11 | 2.48 % | $ 20 B | NYSE | ||
|
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | ||
|
Personalis
PSNL
|
$ 6.0 | 7.91 % | $ 356 M | Nasdaq Global Select Market | ||
|
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | ||
|
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | ||
|
Soleno Therapeutics
SLNO
|
$ 52.93 | 0.02 % | $ 2.69 B | Nasdaq Capital Market | ||
|
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market | ||
|
CareDx, Inc
CDNA
|
$ 20.96 | 1.26 % | $ 1.12 B | Nasdaq Global Market,SPB | ||
|
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | ||
|
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market | ||
|
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | ||
|
Co-Diagnostics
CODX
|
$ 1.61 | 1.26 % | $ 2.14 M | Nasdaq Capital Market | ||
|
Thermo Fisher Scientific
TMO
|
$ 473.89 | 1.54 % | $ 179 B | NYSE,SPB | ||
|
Trinity Biotech plc
TRIB
|
$ 0.6 | -0.22 % | $ 61.9 M | Nasdaq Global Select Market | ||
|
Castle Biosciences
CSTL
|
$ 25.04 | 1.77 % | $ 696 M | Nasdaq Global Market,SPB | ||
|
Twist Bioscience Corporation
TWST
|
$ 59.41 | 4.78 % | $ 3.55 B | Nasdaq Global Select Market,SPB | ||
|
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE | ||
|
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | ||
|
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market | ||
|
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | ||
|
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | ||
|
Charles River Laboratories International
CRL
|
$ 184.56 | -0.45 % | $ 9.15 B | NYSE,SPB | ||
|
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | ||
|
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | ||
|
Waters Corporation
WAT
|
$ 348.79 | 1.76 % | $ 20.8 B | NYSE,SPB | ||
|
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | ||
|
Fulgent Genetics
FLGT
|
$ 15.05 | 1.01 % | $ 455 M | Nasdaq Global Market | ||
|
Guardant Health
GH
|
$ 92.61 | 3.45 % | $ 11.6 B | Nasdaq Global Select Market,SPB | ||
|
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | ||
|
ICON Public Limited Company
ICLR
|
$ 123.81 | 2.05 % | $ 10.2 B | Nasdaq Global Select Market,SPB | ||
|
Illumina
ILMN
|
$ 141.88 | 2.02 % | $ 22.6 B | Nasdaq Global Select Market,SPB | ||
|
Senseonics Holdings
SENS
|
$ 5.38 | 7.6 % | $ 224 M | NYSE American | ||
|
Interpace Biosciences
IDXG
|
$ 2.01 | 0.1 % | $ 8.89 M | Nasdaq Global Select Market | ||
|
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | ||
|
Biomerica
BMRA
|
$ 2.22 | 1.6 % | $ 5.1 M | Nasdaq Capital Market | ||
|
Lantheus Holdings
LNTH
|
$ 85.47 | -0.41 % | $ 5.77 B | Nasdaq Global Select Market,SPB | ||
|
Laboratory Corporation of America Holdings
LH
|
$ 257.38 | 0.09 % | $ 21.4 B | NYSE,SPB | ||
|
Celcuity
CELC
|
$ 139.45 | -1.58 % | $ 6.52 B | Nasdaq Global Select Market | ||
|
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | ||
|
Neogen Corporation
NEOG
|
$ 9.16 | -1.19 % | $ 1.99 B | Nasdaq Global Select Market,SPB | ||
|
Quest Diagnostics Incorporated
DGX
|
$ 189.95 | -0.47 % | $ 21.1 B | NYSE,SPB |